Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020
Background: Understanding the drivers of coverage for vaccines offered in the second year of life (2YL) is a critical focus area for Ghana’s life course approach to vaccination. This study characterizes the predictors of vaccine receipt for 2YL vaccines—meningococcal serogroup A conjugate vaccine (M...
Main Authors: | Pierre Muhoza, Monica P. Shah, Hongjiang Gao, Kwame Amponsa-Achiano, Pamela Quaye, William Opare, Charlotte Okae, Philip-Neri Aboyinga, Kwadwo L. Opare, Melissa T. Wardle, Aaron S. Wallace |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/10/1515 |
Similar Items
-
Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
by: Kadidja Gamougam, et al.
Published: (2015-01-01) -
Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines
by: Rodolfo Villena, et al.
Published: (2018-05-01) -
Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
by: Heidi M. Soeters, et al.
Published: (2017-05-01) -
Current safety issues with quadrivalent meningococcal conjugate vaccines
by: Tanya R. Myers, et al.
Published: (2018-05-01) -
Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020-07-01)